在接受口服抗癌治疗的癌症患者中,未得到满足的信息需求和知识差距
Anna K Moritz1, Wolfgang Fehrmann2, Markus K Schuler3,4
1Chair of Health Services Research, Institute of Medical Sociology, Health Services Research, and Rehabilitation Science (IMVR), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Exploratory research in clinical and social pharmacy
|December 22, 2025
概括
接受口服抗癌疗法 (OAT) 的癌症患者有未满足的信息需求和知识缺口,特别是在药物使用和副作用方面. 优化患者教育和支持对于在家进行安全有效的OAT自我管理至关重要.
科学领域:
- 在瘤学瘤学.
- 患者自我管理
- 卫生识字 卫生识字
背景情况:
- 口服抗癌疗法 (OAT) 越来越多地使用,需要强大的患者自我管理技能.
- 充分的患者信息,咨询和药物素养对于安全有效的家庭OAT至关重要.
- 癌症患者需要特殊的支持,以独立管理复杂的口服疗法.
研究的目的:
- 确定接受OAT的癌症患者中未得到满足的信息需求.
- 确定与OAT管理,相互作用和不良事件相关的知识差距.
- 为OAT患者制定有针对性的教育干预措施提供信息.
主要方法:
- 对接受OAT的癌症患者进行半结构面试的定性内容分析.
- 采访探讨了患者与各种OAT类的经验,包括化疗,抗激素和向疗法.
- 分析的重点是确定与信息需求,知识差距和需求意识相关的主题.
主要成果:
- 在21名接受采访的OAT患者中,发现了与治疗相关的重大信息需求和知识差距.
- 在理解正确的药物使用,潜在的相互作用和管理不良事件方面注意到缺陷.
- 一些患者报告说他们积极避免信息,这表明需要量身定制的沟通策略.
结论:
- 确定的患者需求和知识差距强调了优化OAT信息和咨询的必要性.
- 加强患者的自我管理技能和改善门诊咨询服务对于治疗安全和成功至关重要.
- 研究结果为开发针对OAT的癌症患者的跨专业教育干预提供了基础.
相关概念视频
Nursing Ethical Principles II
2.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.0K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


